Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights
Chemical Communications · 2026 · 62 (3) · 649-671
DOI: 10.1039/d5cc05022g ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2026. Verfasst von Mukund Sudharsan M G und 4 weiteren Autor:innen. Beteiligte Einrichtung: Membrane Protein Biology Group, CSIR - Centre for Cellular & Molecular Biology, Uppal Road, Habsiguda, Hyderabad, Telangana-500007, India. janesh.ccm…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Ion Channels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben.
Abstract (Originalsprache)
Nanobodies offer unprecedented precision for targeting ion channels, with structural biology and AI unlocking new therapeutic avenues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Membrane Protein Biology Group, CSIR - Centre for Cellular & Molecular Biology, Uppal Road, Habsiguda, Hyderabad, Telangana-500007, India. janesh.ccmb@csir.res.in.
- Academy of Scientific and Innovation Research (AcSIR), Ghaziabad, India.
Zitieren
APA
M G, M. S., Baral, S., Mohapatra, S. A., Mahendran, I., & Kumar, J. (2026). Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights. Chemical Communications, 62(3), 649-671. https://doi.org/10.1039/d5cc05022g
Vancouver
M G MS, Baral S, Mohapatra SA, Mahendran I, Kumar J. Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights. Chemical Communications. 2026;62(3):649-671. doi:10.1039/d5cc05022g
BibTeX
@article{MG2026,
author = {M G, Mukund Sudharsan and Baral, Somanath and Mohapatra, Sushree Ankita and Mahendran, Ithayaraja and Kumar, Janesh},
title = {Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {3},
pages = {649--671},
doi = {10.1039/d5cc05022g}
}
EUVIMED